《Clinical And Translational Medicine》雜志的最新年發文量為302篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在醫學：研究與實驗領域的學術影響力。
該刊聚焦于醫學-醫學：研究與實驗領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 4 Weeks 。
Clinical And Translational Medicine 雜志發文統計
文章名稱引用次數
- A perspective on multi-target drug discovery and design for complex diseases89
- Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs64
- The role of CD133 in cancer: a concise review45
- Extracellular vesicles as circulating cancer biomarkers: opportunities and challenges35
- Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms31
- Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer30
- Recent advances in hyaluronic acid based therapy for osteoarthritis28
- Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials27
- Combination therapy to checkmate Glioblastoma: clinical challenges and advances27
- Pancreatic cancer microenvironment: a current dilemma21
國家/地區發文量
- CHINA MAINLAND210
- USA72
- GERMANY (FED REP GER)11
- Iran8
- Sweden8
- Canada7
- France7
- Japan7
- Australia6
- Italy5
